March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
March 29, 2022 – Eko, a digital health company advancing heart and lung disease detection, has announced the launch of ...
March 14, 2022 – Stroke is an acute disease of the brain and the most common cause of permanent disability in adults in ...
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time ...
March 13, 2022 – Philips has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a first ...
March 13, 2022 – People with a congenital heart defect who were hospitalized with COVID-19 infection were at higher risk ...
March 9, 2022 – Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld electrocardio ...
There is a movement toward real-time, remote cardiac monitoring with the latest generation of event and Holter monitor ...
February 28, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the ...
February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart ...
February 14, 2022 — Philips, a global leader in health technology, is supporting the American Heart Association’s multi ...
New patient monitoring technologies with wireless connectivity have enabled a revolution in cardiac event and Holter ...
January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...
January 5, 2022 — Stereotaxis announced a recent publication in Frontiers in Cardiovascular Medicine titled “Atrial ...

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...
November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...